Refine
Has Fulltext
- yes (146) (remove)
Year of publication
- 2015 (146) (remove)
Document Type
- Doctoral Thesis (146) (remove)
Language
- English (146) (remove)
Keywords
- Topologischer Isolator (8)
- Taufliege (5)
- Krebs <Medizin> (4)
- Quecksilbertellurid (4)
- Drosophila (3)
- Elektronischer Transport (3)
- Ereigniskorreliertes Potenzial (3)
- Exziton (3)
- Femtosekundenspektroskopie (3)
- Festkörperphysik (3)
- Ladungstransfer (3)
- Myc (3)
- Selbstorganisation (3)
- Ultrakurzzeitspektroskopie (3)
- Vaccinia-Virus (3)
- Aggregation (2)
- Angiogenese (2)
- Angststörung (2)
- Antigen CD8 (2)
- Arzneimittel (2)
- Aspergillus fumigatus (2)
- Biene (2)
- Biologische Uhr (2)
- Brain-computer interface (2)
- Data Mining (2)
- Dendritische Zelle (2)
- EEG (2)
- Early Basso Continuo (2)
- Early Music (2)
- Echinococcus (2)
- Elektronentransfer (2)
- Finanzmathematik (2)
- Fluoreszenz (2)
- Fotoionisation (2)
- Fuchsbandwurm (2)
- Gehirn-Computer-Schnittstelle (2)
- HgTe (2)
- Inhibitor (2)
- Ionic Liquids (2)
- Kernspintomografie (2)
- Konditionierung (2)
- LHC (2)
- Leishmaniose (2)
- Löslichkeit (2)
- Maschinelles Lernen (2)
- Maus (2)
- Melanom (2)
- Mesenchymzelle (2)
- Molekularbiologie (2)
- Molekulardynamik (2)
- Netzwerk (2)
- Optimale Kontrolle (2)
- P300 (2)
- Performance practice (2)
- Perylenbisimid (2)
- Pharmakokinetik (2)
- Pump-Probe-Technik (2)
- Pyrolyse (2)
- Rezeptor (2)
- Serotonin (2)
- Spintronik (2)
- Supersymmetrie (2)
- Supersymmetry (2)
- Systemisches Risiko (2)
- Theoretische Chemie (2)
- Therapie (2)
- Transkription <Genetik> (2)
- Ultraschnelle Photochemie (2)
- Ultraviolett-Photoelektronenspektroskopie (2)
- West Africa (2)
- Wettbewerb (2)
- Wirkstofffreisetzung (2)
- Zellkultur (2)
- cancer (2)
- charge transfer (2)
- learning and memory (2)
- organic semiconductors (2)
- organische Halbleiter (2)
- physics (2)
- topological insulator (2)
- topological insulators (2)
- ultrafast photochemistry (2)
- (bi)pyridine-based ligand (1)
- 2-APB (1)
- 3 Tesla (1)
- 3-D liver model (1)
- 3D topological insulator (1)
- A-priori-Wissen (1)
- AAC (1)
- ALS (1)
- ASAXS (1)
- ATLAS <Teilchendetektor> (1)
- ATLAS-Detektor (1)
- Abschattung (1)
- Active pharmaceutical ingredients (1)
- Adaptives Immunsystem (1)
- Adenosin (1)
- Adenosine receptors (1)
- Adenosinrezeptor (1)
- Adhäsion (1)
- Adipogenesis (1)
- Advanced Driver Assistance Systems (1)
- Aggregat <Chemie> (1)
- Agrarproduktion (1)
- Alpha Neurofeedback (1)
- Alzheimer`s disease (1)
- Alzheimerkrankheit (1)
- Aminosäuren (1)
- Amphiphile Verbindungen (1)
- Amyotrophe Lateralsklerose (1)
- Analyse (1)
- Analytik (1)
- Angeregter Zustand (1)
- Angiogenesis (1)
- Angst (1)
- Annäherung-Vermeidung (1)
- Anpassungstest (1)
- Anreizsystem (1)
- Antikörper (1)
- Anxiety Disorders (1)
- Apallisches Syndrom (1)
- Apoptose (1)
- Apoptosis (1)
- Application-Aware Resource Management (1)
- Approach-Avoidance (1)
- Arachidonsäure (1)
- Arbeitsteilung (1)
- Arctic (1)
- Artefakt <Bildgebende Diagnostik> (1)
- Arthrose (1)
- Arthrosis deformans (1)
- Arzneimitteldesign (1)
- Arzneimittelforschung (1)
- Arzneimittelmarkt (1)
- Assoziatives Gedächtnis (1)
- Astrozyten (1)
- Audit sampling (1)
- Aufmerksamkeit (1)
- Ausbreitung (1)
- Aversive Konditionierung (1)
- B-Lymphocyten (1)
- B-Lymphozyt (1)
- B-MYB (1)
- B-lymphocytes (1)
- BCI (1)
- Bacillus subtilis (1)
- Bakterielle Infektion (1)
- Banks Islands (1)
- Bariatric surgery (1)
- Bauchspeicheldrüsenkrebs (1)
- Benin (1)
- Benutzerfreundlichkeit (1)
- Benutzerfreundlichkeit/ Benutzbarkeit (1)
- Beschriftung (1)
- Beschriftung von Straßen (1)
- Bewusstsein (1)
- Bewusstseinsstörung (1)
- Bewusstseinsstörungen (1)
- Beyond Standard Model (1)
- Bienen <Familie> (1)
- Biholomorphe Abbildung (1)
- Binomialverteilung (1)
- Biochemie (1)
- Biological Networks (1)
- Biologie / Zellbiologie (1)
- Biologischer Abbau (1)
- Bioverfügbarkeit (1)
- Blockcopolymere (1)
- Bola-Amphiphil (1)
- Bone marrow stromal cell (BMSC) (1)
- Burkitt (1)
- CD1c⁺ mDC (1)
- CD1d (1)
- CD39 (1)
- CD73 (1)
- CD8 (1)
- CD8 T cell (1)
- CD8 T-Zelle (1)
- CO-releasing molecules (1)
- CTL function (1)
- CaMKII (1)
- Carbon Nanotube (1)
- Carrefour (1)
- CePt5 (1)
- Cellular Networks (1)
- ChIP-sequencing (1)
- Charcot-Marie-Syndrom (1)
- Charcot-Marie-Tooth (1)
- Chemische Reinheit (1)
- Chemotherapie (1)
- China (1)
- China Resource (1)
- Chiral-sensitive Specktroskopie (1)
- Chiralität <Chemie> (1)
- Chirurgie (1)
- Chlamydia trachomatis (1)
- Circadian Rhythms (1)
- Circadian clock (1)
- Clec16a (1)
- Complex Systems (1)
- Compound eyes (1)
- Computational Investigation (1)
- Computational chemistry (1)
- Computational drug-design (1)
- Computerkartografie (1)
- Contemporary Philosophy (1)
- Continuous Sample Path (1)
- Controllability (1)
- Controlled release (1)
- Copula (1)
- Copula <Mathematik> (1)
- Costa Rica (1)
- Counterparty Risk (1)
- Crab-Nebel (1)
- Credibility interval (1)
- Crossed Andreev Refexion (1)
- Crossed Andreev Reflection (1)
- Cryptochrom (1)
- CuPc (1)
- Cyclo-AMP (1)
- Cystein (1)
- Cytotoxizität (1)
- D-Norm (1)
- DNA Mismatch repair (1)
- DNA methylation (1)
- DNS-Reparatur (1)
- DREAM (1)
- Darmflora (1)
- Demyelinisierung (1)
- Demökologie (1)
- Depression (1)
- Detektor (1)
- Diabetes mellitus (1)
- Dickdarmkrebs (1)
- Differentialgleichung (1)
- Differentiation (1)
- Diffusion (1)
- Digital Elevation Model (1)
- Digitale Karte (1)
- Dimension 3 (1)
- Dimensional Crossover (1)
- Dirichlet-Reihe (1)
- Dissoziative Photoionisation (1)
- Diversifikation <Biologie> (1)
- Division of labor (1)
- Donor-Photosensibilisator-Akzeptor Triade (1)
- Double Negative B cells (1)
- Drahtloses lokales Netz (1)
- Dreieck (1)
- Driver assistance (1)
- Driving simulation (1)
- Drosophila melanogaster (1)
- Drug design (1)
- Duodenal Jejunal Bypass (1)
- Dünne Schicht (1)
- Dünnschichtsolarzelle (1)
- EPC (1)
- Eierstockkrebs (1)
- Eierstocktumor (1)
- Einzelhandel (1)
- Electrochemical energy storage (1)
- Electrospinning (1)
- Elektroencephalographie (1)
- Elektronencephalographie (1)
- Elektronendichte (1)
- Elektronenkorrelation (1)
- Elektronenstruktur (1)
- Elektronische Eigenschaften (1)
- Elektrophysiologie (1)
- Elliptische Differentialgleichung (1)
- Elongation (Transkription) (1)
- Emery Kivelson line (1)
- Encapsulation (1)
- Endothel (1)
- Energiespeicher (1)
- Energietransfer (1)
- Energietransfer <Mikrophysik> (1)
- Enoyl-acyl-carrier-protein-Reductase <Enoyl-[acyl-carrier-protein]-Reductase> (1)
- Entzündung (1)
- EphA2 (1)
- Ephrin ligand (1)
- Ephrine (1)
- Epigenetic (1)
- Epigenetik (1)
- Europäische Kommission / Generaldirektion Wettbewerb (1)
- Evaluation (1)
- Evaporation-Induced Self-Assembly (1)
- Exact-controllability (1)
- Exciton (1)
- Experimental physics (1)
- Expert System (1)
- Expertensystem (1)
- Exponential smoothing (1)
- Exponential smoothing with covariates (1)
- Extrakt (1)
- Extreme Value Theory (1)
- Extremwertstatistik (1)
- Extremwerttheorie (1)
- FMMs (1)
- FOXM1 (1)
- FabI (1)
- Fahrerassistenzsystem (1)
- Farbstoff (1)
- Fc-Rezeptor (1)
- Fc-receptor (1)
- Fear (1)
- Fear Conditioning (1)
- Fear Extinction (1)
- Femtochemie (1)
- Femtochemistry (1)
- Femtosecond Spectroscopy (1)
- Femtosekunden Pulsformung (1)
- Femtosekundenbereich (1)
- Femtosekundenlaser (1)
- Fettsucht (1)
- Fettzelle (1)
- Fibroblastenwachstumsfaktor (1)
- Financial Networks (1)
- Finanzielle Netzwerke (1)
- Finite-Elemente-Methode (1)
- Firmwert (1)
- Flotillin (1)
- Fluoreszenz-Resonanz-Energie-Transfer (1)
- Fluoreszenzmikroskopie (1)
- Fokker-Planck optimality systems (1)
- Fokker-Planck-Gleichung (1)
- Force Field (1)
- Formmessung (1)
- Fotochemie (1)
- Foxp3 (1)
- Fragmentierung (1)
- Französische Feldwespe (1)
- Free Energy Perturbation (1987 : Princeton, NJ) (1)
- Funktionelle Kernspintomografie (1)
- Furcht (1)
- Future Internet (1)
- G-Protein gekoppelte Rezeptoren (1)
- GABA(A) receptor (1)
- GABA-Rezeptor (1)
- GAS2L3 (1)
- GDF-15 (1)
- Gallium (1)
- Galliumarsenid (1)
- Gamma-Konvergenz (1)
- Gammaastronomie (1)
- Gammastrahlenastronomie (1)
- Gefahrenlernen (1)
- Gehirn-Computer Schnittstelle (1)
- Gelernte Hilflosigkeit (1)
- Generalized Pareto Distribution (1)
- Genetic engineering (1)
- Genexpression (1)
- Geschützte Natur (1)
- Gewebe (1)
- Gitterbaufehler (1)
- Glioblastom (1)
- Glucosetransportproteine (1)
- Goodness-of-Fit Test (1)
- Governance (1)
- Graphene (1)
- Graphentheorie (1)
- Grenzfläche (1)
- Growth (1)
- Growth-differentiation Factor 15 (1)
- HIF-1α (1)
- HLA-G (1)
- Habitat (1)
- Halbleitergrenzflächen (1)
- Halbleiterphysik (1)
- Handelsformat (1)
- Handelsforschung (1)
- Heubacillus (1)
- Heuschrecken <Überfamilie> (1)
- Hexaarylbenzole (1)
- Higgs-Teilchen (1)
- Hilfsmittel (1)
- Hippocampus (1)
- Hochmagnetfeld (1)
- Honeybee (1)
- Honigbiene (1)
- Host cell death (1)
- Hubbard-Modell (1)
- Human Factors (1)
- Human Host (1)
- Hymenoptera (1)
- Hypoxie (1)
- IL-6 Inhibition (1)
- Ileal Trasposition (1)
- Illusorische Korrelation (1)
- Immune (1)
- Immunologie (1)
- Immunology (1)
- Immunsuppression (1)
- Immunsystem (1)
- Impfplan (1)
- Impfung (1)
- Implantat (1)
- Impulsformung (1)
- In vitro (1)
- Information Extraction (1)
- Information Retrieval (1)
- InhA (1)
- Inhibition (1)
- Innovation (1)
- Insulin-like Growth Factor I (1)
- Insulinresistenz (1)
- Interaction analysis (1)
- Interaktive Karten (1)
- Interleukin 4 (1)
- Interleukin 6 (1)
- Internationaler Wettbewerb (1)
- Intracellular replication (1)
- Iridiumkomplexe (1)
- Kapitalverflechtung (1)
- Kapitalverflechtungen (1)
- Kiefernrindenextrakt (1)
- Killerzelle (1)
- Klassifikation (1)
- Klimawandel (1)
- Klimaänderung (1)
- Knochenregeneration (1)
- Knockout <Molekulargenetik> (1)
- Knowledge-based Systems Engineering (1)
- Kohlenmonoxid (1)
- Kohlenstoff-Nanoröhre (1)
- Kohlenwasserstoffe (1)
- Kommunikationshilfe (1)
- Komplement (1)
- Komplexes System (1)
- Kondo cloud (1)
- Kondo effect (1)
- Kondo-Effekt (1)
- Konfidenzintervall (1)
- Konforme Abbildungen (1)
- Konkurrenzanalyse (1)
- Konstruktionsmethoden (1)
- Kontrakttheorie (1)
- Kontrollierte Wirkstofffreisetzung (1)
- Kontrolltheorie (1)
- Kooperativität (1)
- Korrelation (1)
- Korruption (1)
- Korruption von Mitarbeitern (1)
- Kraftfeld (1)
- Kristall (1)
- Kristalloberfläche (1)
- LASP1 (1)
- LC-MS/MS (1)
- LEED (1)
- LIS (1)
- Land Cover Classification (1)
- Landschaftsökologie (1)
- Landwirtschaft (1)
- Laufkäfer (1)
- Lebensmitteleinzelhandel (1)
- Lebensqualität (1)
- Leberepithelzelle (1)
- Leistungsbewertung (1)
- Lepton-Flavour-Verletzung (1)
- Lernen (1)
- Licht (1)
- Lieferantenwahl (1)
- Ligand (1)
- Lipid Rafts (1)
- Ljapunov-Funktion (1)
- Ljapunov-Stabilitätstheorie (1)
- Loewner theory (1)
- Loewner-Theorie (1)
- Logging (1)
- Lokalanästhesie (1)
- Lymphom (1)
- MBE (1)
- MRI (1)
- MRSA (1)
- MSC (1)
- Machine Learning (1)
- Mackenzie-River-Delta (1)
- Magerrasen (1)
- Magnetic resonance (1)
- Magnetischer Röntgenzirkulardichroismus (1)
- Makrophage (1)
- Makrophagen (1)
- Mangan (1)
- Markov-Ketten-Monte-Carlo-Verfahren (1)
- Marktstruktur (1)
- Masern (1)
- Matrix Effekte (1)
- Mehragentensystem (1)
- Melanin (1)
- Melanin release (1)
- Melanomzellen (1)
- Memory B cells (1)
- Mercury Telluride (1)
- Merocyanine (1)
- Merocyanine dye (1)
- Mesenchymale Stammzelle (1)
- Messenger-RNP (1)
- Messenger-RNS (1)
- Metabolismus (1)
- Metagenom (1)
- Metallcarbonyle (1)
- Metallimplantat (1)
- Metastase (1)
- Metro (1)
- Microscopy (1)
- Mikroglia (1)
- Mismatch (1)
- Miz1 (1)
- Mobile Telekommunikation (1)
- Molecular Phenomena (1)
- Molecular Simulation (1)
- Molecular dynamics (1)
- Molecular mechanics (1)
- Molekulare Phänomene (1)
- Molekularstrahlepitaxie (1)
- Moleküldynamik (1)
- Monitoring (1)
- Monoklonaler Antikörper (1)
- Monte Carlo Simulation (1)
- Monte-Carlo Methods (1)
- Monte-Carlo-Simulation (1)
- Moonlight (1)
- Multi-agent systems (1)
- Mumps (1)
- Muskelin (1)
- Myatrophische Lateralsklerose (1)
- Myokarditis (1)
- N400 (1)
- NFAT (1)
- NFATc1 (1)
- NMR-Spektroskopie (1)
- NOD (1)
- NSN-Grenzfächen (1)
- NSN-junctions (1)
- Nanolithografie (1)
- Nanomedicine (1)
- Nanomedizin (1)
- Nanoparticles (1)
- Native Chemical Ligation (1)
- Naturstoff (1)
- Nestbau (1)
- Networks (1)
- Netzwerkmanagement (1)
- Netzwerkverwaltung (1)
- Neue Physik (1)
- Neurofeedback (1)
- Neuronal plasticity (1)
- Neuronale Plastizität (1)
- New physics (1)
- Nichtglatte Optimierung (1)
- Nichtlineare Funktionalgleichung (1)
- Niederdimensionales System (1)
- Nisthilfe (1)
- Nonequilibrium (1)
- Nonparametric Inference (1)
- Nonsmooth optimization (1)
- Nozizeptor (1)
- Numerical Asset Valuation (1)
- Nutzen (1)
- Nutzenvergleich (1)
- Oberfläche (1)
- Oligomerisation (1)
- Oligomerization (1)
- Onboard (1)
- Oncolytic Vaccinia Virus Therapy (1)
- Onkolyse (1)
- Onkolytische Vaccinia Virustherapie (1)
- Opioide (1)
- Optical spectroscopy (1)
- Optimal control problem (1)
- Optimierung (1)
- Optimization (1)
- Optische Spektroskopie (1)
- Order Statistics (1)
- Organisation (1)
- Organisationskultur (1)
- Organisationspsychologie (1)
- Organische Sulfide (1)
- Originators (1)
- Osteoarthritis (1)
- Osteogenesis (1)
- Osteoporose (1)
- PHMB (1)
- PI3K (1)
- Pareto-Verteilung (1)
- Participation (1)
- Period (1)
- Permeabilität (1)
- Peroxiredoxin (1)
- Peroxiredoxin 6 (1)
- Perylenbisdicarboximide <Perylen-3,4:9,10-bis(dicarboximide)> (1)
- Perylenderivate (1)
- Phagosom (1)
- Phagosomal escape (1)
- Phagozytose (1)
- Pharmaceutical markets (1)
- Pharmazeutische Industrie (1)
- Pharmazie (1)
- Phenomenology (1)
- Pheromon (1)
- Pheromon Kommunikation (1)
- Pheromon communication (1)
- Philosophy of Cognitive Science (1)
- Philosophy of Mind (1)
- Photoanregung (1)
- Photoelektron-Photoion-Koinzidenz (1)
- Photoelektronen-Photoionen-Koinzidenz (1)
- Photoelektronenspektroskopie (1)
- Photoluminescence (1)
- Photolumineszenzspektroskopie (1)
- Photosensibilisator (1)
- Physik jenseits des Standardmodells (1)
- Plasmamembran (1)
- PolSAR (1)
- Polarimetrie (1)
- Polarisationspulsformung (1)
- Polistes (1)
- Polo-like kinase 1 (1)
- Polyamin (1)
- Polyethylenglykole (1)
- Polyglycidol (1)
- Polymer (1)
- Polymere (1)
- Polymilchsäure (1)
- Poorly water soluble drugs (1)
- Populationsgenetik (1)
- Prediction interval (1)
- Prefrontalt Cortex (1)
- Preisvergleich (1)
- Probenaufarbeitung (1)
- Processing Fluency (1)
- Produktinnovation (1)
- Prognose (1)
- Prostaglandin E2 (1)
- Proteaseinhibitor (1)
- Proteasomaler Abbau (1)
- Protected Area (1)
- Protein Expression (1)
- Protein crystal (1)
- Protein-Protein-Wechselwirkung (1)
- Proteine (1)
- Proton-Proton-Streuung (1)
- Präferenz (1)
- Präfrontaler Cortex (1)
- Pränatale Entwicklung (1)
- Psychologie (1)
- Pulmonale Applikation (1)
- Pulmonary delivery (1)
- Pulsar (1)
- Punktbeschriftungen (1)
- Pycnogenol (1)
- Quanten-Hall-Effekt (1)
- Quantenchemie (1)
- Quanteninformation (1)
- Quantum control (1)
- RESTORE protocol (1)
- RIXS (1)
- RNA binding proteins (1)
- RNAi (1)
- RNS-Interferenz (1)
- RNS-Polymerase II (1)
- RS1 Peptides (1)
- RS1 derived peptides (1)
- Radarfernerkundung (1)
- Radioastronomie (1)
- Radiofrequenzstrahlung (1)
- Rapsanbau (1)
- Rashba Spin-Orbit Coupling (1)
- Rashba impurity (1)
- Rashba-Effekt (1)
- Ratte (1)
- Raumfahrzeug (1)
- Reaktionsmechanismus (1)
- Reference pricing schemes (1)
- Regulation (1)
- Regulatorischer T-Lymphozyt (1)
- Relevant market (1)
- Relief <Geografie> (1)
- Repression (1)
- Retail (1)
- Rheumatoid arthritis (1)
- Rhizom (1)
- Rhodopsin (1)
- Ribosome (1)
- Riemann Hypothesis (1)
- Riemannsche Zetafunktion (1)
- Risikomanagement (1)
- Risk-sharing schemes (1)
- Routing (1)
- Ru(0001) (1)
- Ruthenium (1)
- Röntgenabsorptionsspektroskopie (1)
- Röntgenemission (1)
- Röntgenspektroskopie (1)
- Röteln (1)
- SAPT (1)
- SQUID (1)
- Salz (1)
- Salzlösung (1)
- Schwere-Fermionen-System (1)
- Seide (1)
- Seiden-Fibroin (1)
- Sekundärwald (1)
- Shaggy (1)
- Shanghai (1)
- Siliciumcarbid (1)
- Silicon carbide (1)
- Silicon vacancy (1)
- Silk Fibroin (1)
- Silk-Fibroin (1)
- Simulation (1)
- Software (1)
- Solarzellen (1)
- Soziales Netzwerk (1)
- Sozialpsychologie (1)
- Spacecrafts (1)
- Spam Detection (1)
- Spermin (1)
- Spin defect (1)
- Spin flip (1)
- Spin systems (1)
- Spinchemie (1)
- Spinsystem (1)
- Spray drying (1)
- Sprungmodell (1)
- Sprühtrocknung (1)
- Stammzelle (1)
- Standardmodell <Elementarteilchenphysik> (1)
- Staphylococcus aureus (1)
- Starry Sky (1)
- Statistics (1)
- Statistische Mechanik (1)
- Statistische Physik (1)
- Step Ru surface (1)
- Stilles Lesen (1)
- Stochastic Process (1)
- Stochastischer Prozess (1)
- Stress (1)
- Structrual Model (1)
- Strukturanalyse (1)
- Subjektive Theorie (1)
- Substruktur (1)
- Supercapacitor (1)
- Superkondensator (1)
- Supersaturation (1)
- Supraleiter (1)
- Supraleitung (1)
- Supramolekulare Chemie (1)
- Synapse (1)
- Synapses (1)
- Synchrotronstrahlung (1)
- Synthetic Aperture Radar (1)
- Systemic Risk (1)
- T Zelle (1)
- T-Lymphozyt (1)
- TI (1)
- TLR7 (1)
- TLR8 (1)
- Tagesrhythmus (1)
- Tagging (1)
- Therapeutical application (1)
- Thermoelektrizität (1)
- Thermoregulation (1)
- Thiol-Ene-Click-Chemie (1)
- Tieftemperatur (1)
- Timeless (1)
- Toll-like-Rezeptoren (1)
- Topografie (1)
- Topological Insulator (1)
- Topological edge states (1)
- Topological insulator (1)
- Topologische Randkanäle (1)
- Toulouse point (1)
- Toxizitätstest (1)
- Traffic Lights (1)
- Traffic psychology (1)
- Transcranial Magnetic Stimulation (1)
- Transcription (1)
- Transient Absorption Spectroscopy (1)
- Transiente Absorptionsspektroskopie (1)
- Transkriptionsfaktor (1)
- Triad (1)
- Tuberkelbakterium (1)
- Tumorerkrankungen (1)
- Twilight (1)
- Typ 2 (1)
- Type 1 Diabetes (1)
- UI and Interaction Design (1)
- Ubiquitinierung (1)
- Ultimatum Game (1)
- Ultrakurzer Lichtimpuls (1)
- Unified Monitoring (1)
- Unternehmen (1)
- Unternehmensbewertung (1)
- Unternehmenskooperation (1)
- Usability (1)
- User Participation (1)
- Vacuum stability (1)
- Valeriana wallichii (1)
- Vascular endothelial Growth Factor (1)
- Vektorboson (1)
- Vektorfeldformer (1)
- Vektorfeldkontrolle (1)
- Verarbeitungsflüssigkeit (1)
- Verbindungen (1)
- Verdunstung (1)
- Verkapselung (1)
- Verkehrsteilnehmer (1)
- Vertikalvereinbarungen (1)
- Verunreinigung (1)
- Verzerrte Kognition (1)
- Verzerrung (1)
- Visualisierung (1)
- Vorläuferzelle (1)
- W Arly Pendjari WAP (1)
- Wahrnehmung (1)
- Web2.0 (1)
- Wechselwirkung (1)
- Wert (1)
- Wespen (1)
- Westafrika (1)
- Wettbewerbsstrategie (1)
- Wireless Mesh Networks (1)
- Wirtszelle (1)
- Wissensbasiertes System (1)
- Word-preferences (1)
- Wort (1)
- Wort-Präferenzen (1)
- Zeitgeber (1)
- Zellteilung (1)
- Zelltod (1)
- Zellzyklus (1)
- Zero-inflation (1)
- Zeta-function (1)
- Zirkulardichroismus Spektroskopie (1)
- active zone (1)
- adaptive immune system (1)
- adipocytes (1)
- adult neurogenesis (1)
- agriculture (1)
- amino acids (1)
- antibodies (1)
- antigen (1)
- antileishmanial (1)
- aqueous solution (1)
- arachidonic acid (1)
- assistive device (1)
- attention (1)
- autoimmunity (1)
- automated map labeling (1)
- automatische Beschriftungsplatzierung (1)
- beyond Standard Model (1)
- biased dispersal (1)
- biodegradable polymer (1)
- biological activity (1)
- biological pest control (1)
- biologische Körperflüssigkeiten (1)
- bola-amphiphile (1)
- bone regeneration (1)
- brain-computer interface (1)
- cAMP (1)
- calcareous grassland (1)
- calpain (1)
- capture-mark-recapture (1)
- carbonmonoxide (1)
- cardiovascular (1)
- cell culture (1)
- charge-separated state (1)
- charged aerosol detector (1)
- chirality-sensitive spectroscopy (1)
- chlamydia (1)
- circular arc polygon domain (1)
- circular dichroism spectroscopy (1)
- click chemistry (1)
- climate change impact (1)
- cognitive bias (1)
- community composition (1)
- complement (1)
- conformal mapping (1)
- cooperativity (1)
- correlation (1)
- corrupt organizational culture (1)
- corruption (1)
- crab pulsar (1)
- crop harvest (1)
- cross-ownership (1)
- ctr (1)
- cytokinesis (1)
- demyelination (1)
- dendritic cells (1)
- depression (1)
- discrete-to-continuum (1)
- disorders of consciousness (1)
- dispersal (1)
- division of labor (1)
- donor-photosensibilisator-acceptor triad (1)
- drug delivery (1)
- drug development (1)
- dünner Filme (1)
- ecosystem services (1)
- electron density (1)
- electronic structure (1)
- electrophysiology (1)
- employees' corruption (1)
- endocytosis (1)
- energy transfer (1)
- ereigniskorrelierte Potentiale (1)
- ergodic transformation (1)
- erweiterte Eichsymmetrie (1)
- eukaryotic gene expression (1)
- evaluation (1)
- event-related potentials (1)
- exciton (1)
- extended gauge symmetry (1)
- extra Eichbosonen (1)
- extra gauge bosons (1)
- femtosecond pulse shaping (1)
- femtosecond spectroscopy (1)
- financial network (1)
- finanzielles Netzwerk (1)
- finite elements (1)
- firm valuation (1)
- fluorescence (1)
- food security (1)
- fracture (1)
- functional magnetic resonance imaging (1)
- gamma astronomy (1)
- gamma-convergence (1)
- gastrointestinal cancer (1)
- giant pulses (1)
- helical liquid (1)
- hexaarylbenzenes (1)
- higher order methods (1)
- honeybee (1)
- hopping model (1)
- hybrid systems (1)
- iNKT (1)
- illusory correlation (1)
- immune cell function (1)
- immune escape (1)
- in vitro (1)
- induced (1)
- inflammation (1)
- inhibition (1)
- insulator (1)
- insulin resistance (1)
- interactive maps (1)
- interleukin-4 (1)
- intracellular replication (1)
- inverse photoemission (1)
- iridium complex (1)
- josephson junction (1)
- kinesin (1)
- knowledge engineering (1)
- korrupte Organisationskultur (1)
- landscape ecology (1)
- large-scale climate circulation (1)
- learned helplessness (1)
- learning-by-doing (1)
- lepton flavour violation (1)
- lowering lattice forces (1)
- mRNA metabolism (1)
- macrophages (1)
- manganese (1)
- melanocytic nevi (1)
- melanoma (1)
- melanoma cancer (1)
- melanoma cells (1)
- mercury (1)
- mesoscopic physics (1)
- mesoskopische Physik (1)
- metagenomic (1)
- metal carbonyl (1)
- metallosupramolecular π-amphiphiles (1)
- microarray (1)
- migration (1)
- mitosis (1)
- molecular dynamics (1)
- multiply connected domain (1)
- mycobacterium tuberculosis (1)
- myocarditis (1)
- nanolithography (1)
- natural enemies (1)
- natural products (1)
- nesting behaviour (1)
- neutron star (1)
- nociceptors (1)
- non-covalent interactions (1)
- nutzerzentrierter Ansatz (1)
- oilseed rape (1)
- oligo(phenylene ethynylene) (OPE) (1)
- oncolytic virotherapy (1)
- oncolytic virus therapy (1)
- onkolytische Virustherapie (1)
- opioid receptors (1)
- optimal control (1)
- oral bioavailability (1)
- organic solar cell (1)
- organic transistor (1)
- organisationale Korruption (1)
- organische Solarzelle (1)
- organischer Transitor (1)
- organizational corruption (1)
- orthoptera (1)
- ovarian cancer (1)
- ovarian carcinoma (1)
- partial differetial equations (1)
- patch connectivity (1)
- permeability (1)
- peroxiredoxin 6 (1)
- perylene bisimide (1)
- pharmaceutical analysis (1)
- pharmacokinetics (1)
- photoelectron spectroscopy (1)
- photoelectron-photoion coincidence (1)
- photoinduced electron transfer (1)
- photoinduzierter Elektronentransfer (1)
- point labeling (1)
- polarimetry (1)
- polarization pulse shaping (1)
- polyamine (1)
- polyethylenglykole (1)
- polylactid (1)
- polymer (1)
- poorly water soluble drugs (1)
- populations genetics (1)
- postsurgical adhesion (1)
- preference construction (1)
- prostaglandin E2 (1)
- proximity effect (1)
- psychophysiology (1)
- pyrolysis (1)
- quantum point contact (1)
- quasi-continuum (1)
- radio astronomy (1)
- random walk (1)
- reactive intermediates (1)
- reaktive Intermediate (1)
- rebate systems (1)
- regional analgesia (1)
- regulation (1)
- repeated dose (1)
- residence time (1)
- resonant inelastic x-ray scattering (1)
- revealed preference (1)
- salt solutions (1)
- sand dynamics (1)
- secondary rainforest fragments (1)
- self-assembly (1)
- self-organized magnetization (1)
- semiconductor (1)
- semiconductor interfaces (1)
- sensitivity (1)
- signalling (1)
- silk fibroin (1)
- single-crystalline Ru surfaces (1)
- snoRNA (1)
- solid dispersion (1)
- spermine (1)
- spillover (1)
- spin (1)
- spin chemistry (1)
- staphylococcus aureus (1)
- steady-state visually evoked potentials (1)
- steered molecular dynamics (1)
- street labeling (1)
- streptozotocin (1)
- structural model (1)
- structure-function relationships (1)
- super-resolution microscopy (1)
- superconductivity (1)
- systematic review (1)
- systemic risk (1)
- telluride (1)
- theoretical chemistry (1)
- thermodynamics (1)
- thin film (1)
- threat learning (1)
- topological (1)
- topologische Isolatoren (1)
- toxicity testing (1)
- transaction utility (1)
- transfer (1)
- tumor vascularization (1)
- usability (1)
- user-centred design (1)
- utility (1)
- vacancy (1)
- vaccination program (1)
- vaccinia virus (1)
- vector-field control (1)
- vector-field shaper (1)
- verdunstungsinduzierter Selbstanordnung (1)
- vertical agreements (1)
- virotherapy (1)
- visualization (1)
- x-ray emission (1)
- Überwachungstechnik (1)
- Übung (1)
Institute
- Graduate School of Life Sciences (32)
- Theodor-Boveri-Institut für Biowissenschaften (26)
- Physikalisches Institut (14)
- Institut für Mathematik (13)
- Institut für Pharmazie und Lebensmittelchemie (10)
- Institut für Physikalische und Theoretische Chemie (10)
- Institut für Psychologie (10)
- Institut für Theoretische Physik und Astrophysik (8)
- Institut für Informatik (7)
- Institut für Organische Chemie (6)
Sonstige beteiligte Institutionen
- ATLAS Collaboration (1)
- Adam Opel AG (1)
- CERN (1)
- Deutscher Akademischer Austauschdienst (DAAD) (1)
- Deutsches Zentrum für Luft- und Raumfahrt (DLR), Institut für Raumfahrtsysteme (1)
- Institut für Hygiene und Mikrobiologie (1)
- Instituto de Higiene, Universidad de la República, Montevideo, Uruguay (1)
- König-Ludwig-Haus, Orthopedic Clinic, Würzburg (1)
- Novartis AG (1)
- OTH Regensburg (1)
ResearcherID
- B-1911-2015 (1)
- C-2593-2016 (1)
- N-2030-2015 (1)
- N-3741-2015 (1)
The thesis focuses on the valuation of firms in a system context where cross-holdings of the firms in liabilities and equities are allowed and, therefore, systemic risk can be modeled on a structural level. A main property of such models is that for the determination of the firm values a pricing equilibrium has to be found. While there exists a small but growing amount of research on the existence and the uniqueness of such price equilibria, the literature is still somewhat inconsistent. An example for this fact is that different authors define the underlying financial system on differing ways. Moreover, only few articles pay intense attention on procedures to find the pricing equilibria. In the existing publications, the provided algorithms mainly reflect the individual authors' particular approach to the problem. Additionally, all existing methods do have the drawback of potentially infinite runtime.
For these reasons, the objects of this thesis are as follows. First, a definition of a financial system is introduced in its most general form in Chapter 2. It is shown that under a fairly mild regularity condition the financial system has a unique existing payment equilibrium. In Chapter 3, some extensions and differing definitions of financial systems that exist in literature are presented and it is shown how these models can be embedded into the general model from the proceeding chapter. Second, an overview of existing valuation algorithms to find the equilibrium is given in Chapter 4, where the existing methods are generalized and their corresponding mathematical properties are highlighted. Third, a complete new class of valuation algorithms is developed in Chapter 4 that includes the additional information whether a firm is in default or solvent under a current payment vector. This results in procedures that are able find the solution of the system in a finite number of iteration steps. In Chapter 5, the developed concepts of Chapter 4 are applied to more general financial systems where more than one seniority level of debt is present. Chapter 6 develops optimal starting vectors for non-finite algorithms and Chapter 7 compares the existing and the new developed algorithms concerning their efficiency in an extensive simulation study covering a wide range of possible settings for financial systems.
A series of combustion relevant species like radicals, carbenes and polycyclic aromatic hydrocarbons were characterized in the gas phase by vacuum UV synchrotron radiation and their ionization energies (IE) and further spectroscopic details of the respective cations were retrieved from threshold photoelectron spectra. The reactive intermediates were generated by flash vacuum pyrolysis from stable precursor molecules. Furthermore three polycyclic aromatic hydrocarbons were investigated by threshold photoelectron spectroscopy, too. The experiment was performed at the VUV beamline of the Swiss Light Source in Villigen/Switzerland and the iPEPICO (imaging photoelectron photoion coincidence) setup was applied to correlate ions and electrons from the same ionization event. From the threshold photoelectron spectra and from quantum chemical computations the vibrational structure of the molecule cations and the geometry changes upon ionization were assigned. The ionization energies of the two C4H5 isomers 2-butyn-1-yl and 1-butyn-3-yl were assigned to 7.94±0.02 eV and 7.97±0.02 eV, respectively. The isomerization between the two isomers was computed to have a barrier of 2.20 eV, so a rearrangement between the two radicals cannot be excluded. From the threshold photoelectron spectra of the two constitutional C4H7 isomers 1-methylallyl and 2-methylallyl the ionization energies were assigned to 7.48±0.02 eV and to 7.59±0.02 eV for 1-E-methylallyl and 1-Z-methylallyl, as well as to 7.88±0.01 eV for 2-methylallyl. The two radicals 9-fluorenyl, C13H9, and benzhydryl, C13H11, were observed to ionize at 7.01±0.02 eV and 6.7 eV. The threshold photoelectron spectrum of benzhydryl also incorporated the signal of the diphenylmethyl carbene, C13H10, which has an IE at 6.8 eV. In addition, the head-to-head dimers of 9-fluorenyl and benzhydryl were observed as products in the pyrolysis. C26H18 has an IE at 7.69±0.04 eV and C26H22 has an IE at 8.13±0.04 eV. The three polycyclic aromatic hydrocarbon DHP (C14H16) 1-PEN (C18H22) and THCT (C22H16) were investigated in an effusive beam. The ionization energies were determined to IE(DHP)= 7.38±0.02 eV, IE(1-PEN)=7.58±0.05 eV and IE(THCT)=6.40±0.02 eV. Furthermore the thermal decomposition and the dissociative photoionization of diazomeldrum’s acid was investigated. The pyrolysis products yielded beside several other products the two not yet (by photoelectron spectroscopy) characterized molecules E-formylketene, C3O2H2 and 2-diazoethenone, N2C2O. The dissociative photoionization showed the Wolff rearrangement to occur at higher internal energies.
One of the most popular extensions of the SM is Supersymmetry (SUSY). It is a symmetry relating fermions and bosons and also the only feasible extension to the symmetries of spacetime. With SUSY it is then possible to explain some of the open questions left by the SM while at the same time opening the possibility of gauge unification at a high scale. SUSY theories require the addition of new particles, in particular an extra Higgs doublet and at least as many new scalars as fermions in the SM. Much in the same way that the Higgs boson breaks SU (2)L symmetry, these new scalars can break any symmetry for which they carry a charge through spontaneous symmetry breaking.
Let us assume there is a local minimum of the potential that reproduces the correct phenomenol- ogy for a parameter point of a given model. By exploring whether there are other deeper minima with VEVs that break symmetries we want to conserve, like SU (3)C or U (1)EM , it is possible to exclude regions of parameter space where that happens. The local minimum with the correct phenomenology might still be metastable, so it is also necessary to calculate the probability of tunneling between minima.
In this work we propose and apply a framework to constrain the parameter space of models with many scalars through the minimization of the one-loop eff e potential and the calculation of tunneling times at zero and non zero temperature.After a brief discussion about the shortcomings of the SM and an introduction of the basics of SUSY, we introduce the theory and numerical methods needed for a successful vacuum stability analysis. We then present Vevacious, a public code where we have implemented our proposed framework. Afterwards we go on to analyze three interesting examples.
For the constrained MSSM (CMSSM) we explore the existence of charge- and color- breaking (CCB) minima and see how it constraints the phenomenological relevant region of its parameter space at T = 0. We show that the regions reproducing the correct Higgs mass and the correct relic density for dark matter all overlap with regions suffering from deeper CCB minima.
Inspired by the results for the CMSSM, we then consider the natural MSSM and check the region of parameter space consistent with the correct Higgs mass against CCB minima at T /= 0. We find that regions of parameter space with CCB minima overlap significantly with that reproducing the correct Higgs mass. When thermal eff are considered the majority of such points are then found to have a desired symmetry breaking minimum with very low survival probability. In both these studies we find that analytical conditions presented in the literature fail in dis- criminating regions of parameter space with CCB minima. We also present a way of adapting our framework so that it runs quickly enough for use with parameter fit studies.
Lastly we show a different example of using vacuum stability in a phenomenological study. For the BLSSM we investigate the violation of R-parity through sneutrino VEVs and where in parameter space does this happen. We find that previous analyses in literature fail to identify regions with R-parity conservation by comparing their results to our full numerical analysis.
Tumor-induced angiogenesis is of major interest for oncology research. Vascular endothelial growth factor (VEGF) is the most potent angiogenic factor characterized so far. VEGF blockade was shown to be sufficient for angiogenesis inhibition and subsequent tumor regression in several preclinical tumor models. Bevacizumab was the first treatment targeting specifically tumor-induced angiogenesis through VEGF blockade to be approved by the Food and Drugs Administration (FDA) for cancer treatment. However, after very promising results in preclinical evaluations, VEGF blockade did not show the expected success in patients. Some tumors became resistant to VEGF blockade. Several factors have been accounted responsible, the over-expression of other angiogenic factors, the noxious influence of VEFG blockade on normal tissues, the selection of hypoxia resistant neoplastic cells, the recruitment of hematopoietic progenitor cells and finally the transient nature of angiogenesis inhibition by VEGF blockade. The development of blocking agents against other angiogenic factors like placental growth factor (PlGF) and Angiopoietin-2 (Ang-2) allows the development of an anti-angiogenesis strategy adapted to the profile of the tumor.
Oncolytic virotherapy uses the natural propensity of viruses to colonize tumors to treat cancer. The recombinant vaccinia virus GLV-1h68 was shown to infect, colonize and lyse several tumor types. Its descendant GLV-1h108, expressing an anti-VEGF antibody, was proved in previous studies to inhibit efficiently tumor induced angiogenesis. Additional VACVs expressing single chain antibodies (scAb) antibodies against PlGF and Ang-2 alone or in combination with anti VEGF scAb were designed.
In this study, VACV-mediated anti-angiogenesis treatments have been evaluated in several preclinical tumor models. The efficiency of PlGF blockade, alone or in combination with VEGF, mediated by VACV has been established and confirmed. PlGF inhibition alone or with VEGF reduced tumor burden 5- and 2-folds more efficiently than the control virus, respectively.
Ang-2 blockade efficiency for cancer treatment gave controversial results when tested in different laboratories. Here we demonstrated that unlike VEGF, the success of Ang-2 blockade is not only correlated to the strength of the blockade. A particular balance between Ang-2, VEGF and Ang-1 needs to be induced by the treatment to see a regression of the tumor and an improved survival. We saw that Ang-2 inhibition delayed tumor growth up to 3-folds compared to the control virus. These same viruses induced statistically significant tumor growth delays. This study unveiled the need to establish an angiogenic profile of the tumor to be treated as well as the necessity to better understand the synergic effects of VEGF and Ang-2. In addition angiogenesis inhibition by VACV-mediated PlGF and Ang-2 blockade was able to reduce the number of metastases and migrating tumor cells (even more efficiently than VEGF blockade).
VACV colonization of tumor cells, in vitro, was limited by VEGF, when the use of the anti-VEGF VACV GLV-1h108 drastically improved the colonization efficiency up to 2-fold, 72 hours post-infection. These in vitro data were confirmed by in vivo analysis of tumors. Fourteen days post-treatment, the anti-VEGF virus GLV-1h108 was colonizing 78.8% of the tumors when GLV-1h68 colonization rate was 49.6%. These data confirmed the synergistic effect of VEGF blockade and VACV replication for tumor regression.
Three of the tumor cell lines used to assess VACV-mediated angiogenesis inhibition were found, in certain conditions, to mimic either endothelial cell or pericyte functions, and participate directly to the vascular structure. The expression by these tumor cells of e-selectin, p-selectin, ICAM-1 and VCAM-1, normally expressed on activated endothelial cells, corroborates our findings. These proteins play an important role in immune cell recruitment, and there amount vary in presence of VEGF, PlGF and Ang-2, confirming the involvement of angiogenic factors in the immuno-modulatory abilities of tumors.
In this study VACV-mediated angiogenesis blockade proved its potential as a therapeutic agent able to treat different tumor types and prevent resistance observed during bevacizumab treatment by acting on different factors. First, the expression of several antibodies by VACV would prevent another angiogenic factor to take over VEGF and stimulate angiogenesis. Then, the ability of VACV to infect tumor cells would prevent them to form blood vessel-like structures to sustain tumor growth, and the localized delivery of the antibody would decrease the risk of adverse effects. Next, the blockade of angiogenic factors would improve VACV replication and decrease the immune-modulatory effect of tumors. Finally the fact that angiogenesis blockade lasts until total regression of the tumor would prevent the recovery of the tumor-associated vasculature and the relapse of patients.
Use of polyhexanide and nanomedicine approach for effective treatments of cutaneous leishmaniasis
(2015)
Despite huge suffering caused by cutaneous leishmaniasis (CL), there is no effective and affordable treatment strategy against CL and no licensed vaccines. The current treatments show limited efficacy and high toxicity. Improved therapies through discovery of novel drugs and/or an alternative treatment approaches are/is urgently needed. We aimed at identifying a novel antileishmanial agent and developing an innovative nanoparticle (NP) based platform for safe and effective treatments against CL. We discovered that polyhexanide (PHMB), a widely used antimicrobial polymer and wound antisepsis, shows an inherent antileishmanial activity at submicromolar concentrations. PHMB appears to kill L. major parasites via a dual mechanism involving disruption of membrane integrity and selective chromosome condensation. However, host chromosomes binding appear to be limited by exclusion from mammalian cell nuclei. Moreover, we attempted to establish effective drug delivery systems that overcome the various shortcomings in the present treatment of CL. In this scenario, we initially studied the cellular interactions of NPs and their uptake mechanisms into mammalian cells before applying them in drug delivery system. We obtained clear evidence for the involvement of multiple endocytic routes to internalize NPs. Physicochemical properties of NPs, cell type, temperature and pathogenesis of the target diseases were shown to be determinant factors. Thereafter, a mechanism based host- and pathogen-directed combination therapy comprising PHMB and CpG ODN immunomodulator was established for overall synergistic effect against CL. It simultaneously targets the pathogen and the host immunity with effective delivery system. The results show that PHMB binds to CpG ODN and form stable nanopolyplexes for efficient cell entry and therapy. The nanopolyplexes displayed enhanced cellular uptake and antileishmanial potency while drastically reducing the toxicity against mammalian cells. In conclusion, our findings clearly indicate that PHMB can be used as effective candidate drug against CL and as non-viral delivery of immunomodulatorynucleic acids. Moreover, our proof-of concept study showed nanomedicine approaches are effective strategy to challenge CL and other human diseases.
Within this thesis a new philosophy in monitoring spacecrafts is presented: the
unification of the various kinds of monitoring techniques used during the
different lifecylce phases of a spacecraft.
The challenging requirements being set for this monitoring framework are:
- "separation of concerns" as a design principle (dividing the steps of logging
from registered sources, sending to connected sinks and displaying of
information),
- usage during all mission phases,
- usage by all actors (EGSE engineers, groundstation operators, etc.),
- configurable at runtime, especially regarding the level of detail of logging
information, and
- very low resource consumption.
First a prototype of the monitoring framework was developed as a support library
for the real-time operating system
RODOS. This prototype was tested on dedicated hardware platforms relevant for
space, and also on a satellite demonstrator used for educational purposes.
As a second step, the results and lessons learned from the development and usage
of this prototype were transfered to a real space mission: the first satellite
of the DLR compact satellite series - a space based platform for DLR's own
research activities. Within this project, the software of the avionic subsystem
was supplemented by a powerful logging component, which enhances the traditional
housekeeping capabilities and offers extensive filtering and debugging
techniques for monitoring and FDIR needs. This logging component is the major
part of the flight version of the monitoring framework. It is completed by
counterparts running on the development computers and as well as the EGSE
hardware in the integration room, making it most valuable already in the
earliest stages of traditional spacecraft development.
Future plans in terms of adding support from the groundstation as well will lead
to a seamless integration of the monitoring framework not only into to the
spacecraft itself, but into the whole space system.
Knowledge-based systems (KBS) face an ever-increasing interest in various disciplines and contexts. Yet, the former aim to construct the ’perfect intelligent software’ continuously shifts to user-centered, participative solutions. Such systems enable users to contribute their personal knowledge to the problem solving process for increased efficiency and an ameliorated user experience. More precisely, we define non-functional key requirements of participative KBS as: Transparency (encompassing KBS status mediation), configurability (user adaptability, degree of user control/exploration), quality of the KB and UI, and evolvability (enabling the KBS to grow mature with their users). Many of those requirements depend on the respective target users, thus calling for a more user-centered development. Often, also highly expertise domains are targeted — inducing highly complex KBs — which requires a more careful and considerate UI/interaction design. Still, current KBS engineering (KBSE) approaches mostly focus on knowledge acquisition (KA) This often leads to non-optimal, little reusable, and non/little evaluated KBS front-end solutions.
In this thesis we propose a more encompassing KBSE approach. Due to the strong mutual influences between KB and UI, we suggest a novel form of intertwined UI and KB development. We base the approach on three core components for encompassing KBSE:
(1) Extensible prototyping, a tailored form of evolutionary prototyping; this builds on mature UI prototypes and offers two extension steps for the anytime creation of core KBS prototypes (KB + core UI) and fully productive KBS (core KBS prototype + common framing functionality). (2) KBS UI patterns, that define reusable solutions for the core KBS UI/interaction; we provide a basic collection of such patterns in this work. (3) Suitable usability instruments for the assessment of the KBS artifacts. Therewith, we do not strive for ’yet another’ self-contained KBS engineering methodology. Rather, we motivate to extend existing approaches by the proposed key components. We demonstrate this based on an agile KBSE model.
For practical support, we introduce the tailored KBSE tool ProKEt. ProKEt offers a basic selection of KBS core UI patterns and corresponding configuration options out of the box; their further adaption/extension is possible on various levels of expertise. For practical usability support, ProKEt offers facilities for quantitative and qualitative data collection. ProKEt explicitly fosters the suggested, intertwined development of UI and KB. For seamlessly integrating KA activities, it provides extension points for two selected external KA tools: For KnowOF, a standard office based KA environment. And for KnowWE, a semantic wiki for collaborative KA. Therewith, ProKEt offers powerful support for encompassing, user-centered KBSE.
Finally, based on the approach and the tool, we also developed a novel KBS type: Clarification KBS as a mashup of consultation and justification KBS modules. Those denote a specifically suitable realization for participative KBS in highly expertise contexts and consequently require a specific design. In this thesis, apart from more common UI solutions, we particularly also introduce KBS UI patterns especially tailored towards Clarification KBS.
Time and Spatially Resolved Photoluminescence Spectroscopy of Hot Excitons in Gallium Arsenide
(2015)
The present thesis investigates the impact of hot exciton effects on the low-temperature time and spatially resolved photoluminescence (PL) response of free excitons in high-purity gallium arsenide (GaAs). The work at hand extends available studies of hot carrier effects, which in bulk GaAs have up to now focused on hot electron populations. In crucial distinction from previous work, we extensively study the free exciton second LO-phonon replica. The benefit of this approach is twofold. First, the two LO phonon-assisted radiative recombination allows to circumvent the inherent interpretation ambiguities of the previously investigated free exciton zero-phonon line. Second, the recombination line shape of the second LO-phonon replica provides direct experimental access to the exciton temperature, thereby enabling the quantitative assessment of hot exciton effects.
In the first part of the thesis, we address the influence of transient cooling on the time evolution of an initially hot photocarrier ensemble. To this end, we investigate time-resolved photoluminescence (TRPL) signals detected on the free exciton second LO-phonon replica. Settling a long-standing question, we show by comparison with TRPL transients of the free exciton zero-phonon line that the slow free exciton photoluminescence rise following pulsed optical excitation is dominated by the slow buildup of a free exciton population and not by the relaxation of large K-vector excitons to the Brillouin zone center. To establish a quantitative picture of the delayed photoluminescence onset, we determine the cooling dynamics of the initially hot photocarrier cloud from a time-resolved line shape analysis of the second LO-phonon replica. We demonstrate that the Saha equation, which fundamentally describes the thermodynamic population balance between free excitons and the uncorrelated electron-hole plasma, directly translates the experimentally derived cooling curves into the time-dependent conversion of unbound electron-hole pairs into free excitons.
In the second part of the thesis, we establish the impact of hot exciton effects on low-temperature spatially resolved photoluminescence (SRPL) studies. Such experiments are widely used to investigate charge carrier and free exciton diffusion in semiconductors and semiconductor nanostructures. By SRPL spectroscopy of the second LO-phonon replica, we show that above-band gap focused laser excitation inevitably causes local heating in the carrier system, which crucially affects the diffusive expansion of a locally excited exciton packet. Undistorted free exciton diffusion profiles, which are correctly described by the commonly used formulation of the photocarrier diffusion equation, are only observed in the absence of spatial temperature gradients. At low sample temperatures, the reliable determination of free exciton diffusion coefficients from both continuous-wave and time-resolved SRPL spectroscopy requires strictly resonant optical excitation.
Using resonant laser excitation, we observe the dimensional crossover of free exciton diffusion in etched wire structures of a thin, effectively two-dimensional GaAs epilayer. When the lateral wire width falls below the diffusion length, the sample geometry becomes effectively one-dimensional. The exciton diffusion profile along the wire stripe is then consistently reproduced by the steady-state solution to the one-dimensional diffusion equation.
Finally, we demonstrate the formation of macroscopic free and bound exciton photoluminescence rings in bulk GaAs around a focused laser excitation spot. Both ring formation effects are due to pump-induced local heating in the exciton system. For a quantitative assessment of the mechanism underlying the free exciton ring formation, we directly determine the exciton temperature gradient from a spatially resolved line shape analysis of the free exciton second LO-phonon replica. We demonstrate that a pump-induced hot spot locally modifies the thermodynamic population balance between free excitons and unbound electron-hole pairs described by the Saha equation, which naturally explains the emergence of macroscopic free exciton ring structures.
In summary, we demonstrate that quantitative consideration of hot exciton effects provides a coherent picture both of the time-domain free exciton luminescence kinetics and of the distinct spatially resolved photoluminescence patterns developing under the influence of spatial photocarrier diffusion.
SUMMARY
Insulin-like growth factor I (IGF-I) is a polypeptide with a molecular weight of 7.649 kDa and an anabolic potential. Thereby, IGF-I has a promising therapeutic value e.g. in muscle wasting diseases such as sarcopenia. IGF-I is mainly secreted by the liver in response to growth hormone (GH) stimulation and is rather ubiquitously found within all tissues. The effects of IGF-I are mediated by its respective IGF-I transmembrane tyrosine kinase receptor triggering the stimulation of protein synthesis, glucose uptake and the regulation of cell growth. The actions of IGF-I are modulated by six IGF binding proteins binding and transporting IGF-I in a binary or ternary complex to tissues and receptors and modulating the binding of IGF-I to its receptor. The nature of the formed complexes impacts IGF-I`s half-life, modulating the half-life between 10 minutes (free IGF-I) to 12 - 15 hours when presented in a ternary complex with IGF binding protein 3 and an acid labile subunit (ALS). Therefore, sustained drug delivery systems of free IGF-I are superficially seen as interesting for the development of controlled release profiles, as the rate of absorption is apparently and easily set slower by simple formulation as compared to the rapid rate of elimination. Thereby, one would conclude, the formulation scientist can rapidly develop systems for which the pharmacokinetics of IGF-I are dominated by the formulation release kinetics. However, the in vivo situation is more complex and as mentioned (vide supra), the half-life may easily be prolonged up to hours providing proper IGF-I complexation takes place upon systemic uptake. These and other aspects are reviewed in Chapter I, within which we introduce IGF-I as a promising therapeutic agent detailing its structure and involved receptors along with the resulting signaling pathways. We summarize the control of IGF-I pharmacokinetics in nature within the context of its complex system of 6 binding proteins to control half-life and tissue distribution. Furthermore, we describe IGF-I variants with modulated properties in vivo and originated from alternative splicing. These insights were translated into sophisticated IGF-I delivery systems for therapeutic use. Aside from safety aspects, the challenges and requirements of an effective IGF-I therapy are discussed. Localized and systemic IGF-I delivery strategies, different routes of administration as well as liquid and solid IGF-I formulations are reviewed. Effective targeting of IGF-I by protein decoration is outlined and consequently this chapter provides an interesting guidance for successful IGF-I-delivery. In Chapter II, we firstly outline the stability of IGF-I in liquid formulations with the intention to deliver the biologic through the lung and the impact of buffer type, sodium chloride concentration and pH value on IGF-I stability is presented. IGF-I integrity was preserved in histidine buffer over 4 months at room temperature, but methionine 59 oxidation (Met(o)) along with reducible dimer and trimer formation was observed in an acidic environment (pH 4.5) and using acetate buffer. Strong aggregation resulted in a complete loss of IGF-I bioactivity, whereas the potency was partly maintained in samples showing a slight aggregation and complete IGF-I oxidation. Atomization by air-jet or vibrating-mesh nebulizers yielded in limited Met(o) formation and no aggregation. The results of IGF-I nebulization experiments regarding aerosol output rate, mass median aerodynamic diameter and fine particle fraction were comparable with 0.9% sodium chloride reference, approving the applicability of liquid IGF-I formulations for pulmonary delivery. In Chapter III we escalated the development to solid delivery systems designed for alveolar landing upon inhalation and by deploying trehalose and the newly introduced for pulmonary application silk-fibroin as carriers. Microparticles were produced using nano spray drying following analyses including IGF-I integrity, IGF-I release profiles and aerodynamic properties. In vitro transport kinetics of IGF-I across pulmonary Calu-3 epithelia were suggesting similar permeability as compared to IGF-I’s cognate protein, insulin that has already been successfully administered pulmonary in clinical settings. These in vivo results were translated to an ex vivo human lung lobe model. This work showed the feasibility of pulmonary IGF-I delivery and the advantageous diversification of excipients for pulmonary formulations using silk-fibroin. Chapter IV focuses on an innovative strategy for safe and controllable IGF-I delivery. In that chapter we escalated the development to novel IGF-I analogues. The intention was to provide a versatile biologic into which galenical properties can be engineered through chemical synthesis, e.g. by site directed coupling of polymers to IGF-I. For this purpose we genetically engineered two IGF-I variants containing an unnatural amino acid at two positions, respectively, thereby integrating alkyne functions into the primary sequence of the protein. These allowed linking IGF-I with other molecules in a site specific manner, i.e. via a copper catalyzed azide-alkyne Huisgen cycloaddition (click reaction). In this chapter we mainly introduce the two IGF-I variants, detail the delivery concept and describe the optimization of the expression conditions of the IGF-I variants.
In conclusion, we span from simple liquid formulations for aerolization through solid systems for tailored for maximal alveolar landing to novel engineered IGF-I analogues. Thereby, three strategies for advanced IGF-I delivery were addressed and opportunities and limitations of each were outlined. Evidence was provided that sufficiently stable and easy to manufacture formulations can be developed as typically required for first in man studies. Interestingly, solid systems – typically introduced in later stages of pharmaceutical development – were quite promising. By use of silk-fibroin as a new IGF-I carrier for pulmonary administration, a new application was established for this excipient. The demonstrated success using the ex vivo human lung lobe model provided substantial confidence that pulmonary IGF-I delivery is possible in man. Finally, this work describes the expression of two IGF-I variants containing two unnatural amino acids to implement an innovative strategy for IGF-I delivery. This genetic engineering approach was providing the fundament for novel IGF-I analogues. Ideally, the biologic is structurally modified by covalently linked moieties for the control of pharmacokinetics or for targeted delivery, e.g. into sarcopenic muscles. One future scenario is dicussed in the ‘conclusion and outlook’ section for which IGF-I is tagged to a protease sensitive linker peptide and this linker peptide in return is coupled to a polyethylenglykole (PEG) polymer (required to prolong the half-life). Some proteases may serve as proxy for sarcopenia such that protease upregulation in compromised muscle tissues drives cleavage of IGF-I from the PEG. Thereby, IGF-I is released at the seat of the disease while systemic side effects are minimized.
Theoretical Investigations on the Interactions of Small Compounds with their Molecular Environments
(2015)
In the first part of this work, a combination of theoretical methods for the rational design of covalent inhibitor is presented. Starting from the crystal structure of the covalent complex of a lead compound, quantum mechanical and QM/MM calculations were used to derive the exact geometry of the preceeding non-covalent enzyme inhibitor complex. The geometry of the latter mainly determines the reactivity of the inhibitor against its target enzyme concerning the formation of the covalent bond towards an active site residue. Therefore, this geometry was used as starting point for the optimization of the substitution pattern of the inhibitor such as to increase its binding affinity without loosing its ability to covalently bind to the target protein. The optimization of the chemical structure was supported by using docking procedures, which are best suited to estimate binding affinities that arise from the introduced changes. A screening of the novel substitution patterns resulted in a first generation of model compounds which were further tested for their reactivity against the target. Dynamic simulations on the novel compounds revealed that the orientation that compounds adopt within the active site are such that a covalent interaction with the enzyme is no longer possible. Hence, the chemical structure was further modified, including not only changes in the substituents but also within the core of the molecule. Docking experiments have been conducted to assure sufficiently high binding affinities and to obtain the most favored binding poses. Those have then again been used for dynamic simulations which resulted in structures, for which the bond formation process appeared feasible. A final series of QM/MM calculations considering various protonation states was computed to estimate the reaction energies for the covalent attachment of the inhibitor to the enzyme. The theoretical results indicate a reasonable high inhibition potency of the novel compounds.
The second part concentrates on the environmental influences on the electron density of an inhibitor molecule. Therefore, a vinylsulfone-based model compound was selected for which an experimental crystal structure for the pure compound as well as a theoretically determined enzyme-inhibitor complex have been available. To provide reference data for the larger systems, the conformational space of the isolated molecule was screened for favorable geometries which were later compared to those within the crystal and protein surrounding. The geometry of the crystal structure could readily be taken from the experimental data whereas calculations on the protein complex revealed four potential non-covalent complexes exhibiting different arrangements of the molecule within the active site of the protein as well as two possible protonation states of the catalytic dyad. Hence, all four protein complexes have been compared to the crystal structure of the molecule as well as against the more favorable geometries of the isolated molecule being determined within vacuum or aqueous surrounding. Whereas the molecule itself was found to adopt comparable geometries within all investigated environments, the interactions pattern between the crystal surrounding and the protein differed largely from each other. The favorable formation of dimers within the crystal has a strong stabilizing effect and explains the extraordinarily good quality of the crystal. Within the protein however, repulsive forces have been found between the protein and the inhibitor. The origin of the repulsion could be traced back to effect of on of the substituents to the vinyl scaffold. The difference in the chemical structure in comparison to a well known inhibitor might also explain the experimentally found loss of activity for the model compound in comparison to K11777.